tazobactam has been researched along with Peritonitis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Almind, SR; Andreasen, MR; Frimodt-Møller, N; Hansen, KH; Hertz, FB; Jelsbak, L; Nielsen, KL; Schønning, K | 1 |
| Canovas, J; Chau, F; Fantin, B; Le Monnier, A; Lefort, A; Petitjean, G | 1 |
| Ledger, TS | 1 |
| Faltýn, J; Lochmann, O; Vyhnánek, F | 1 |
| Zaĭtsev, AA | 1 |
| Bette, M; Menendez, S; Mutters, R; Nüsing, RM; Schulz, S; Zamora, ZB | 1 |
| Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Mocchegiani, F; Orlando, F; Riva, A; Rocchi, M; Saba, V; Scalise, G; Silvestri, C | 1 |
| Abbruzzetti, A; Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Aldridge, KE | 1 |
| Grundel, E; Vestweber, KH | 1 |
| Hirayama, T; Iwai, S; Mashita, K; Matsuno, S; Nakagawa, Y; Otsuka, K; Rikiyama, T; Shinagawa, N; Tanaka, T; Yura, J | 1 |
| Barie, PS; Cheadle, WG; Fink, MP; Garber, GE; Hebert, JC; Laverdiere, M; Polk, HC; Wilson, SE | 1 |
| Klimonova, NV; Lobakov, AI; Nasonov, VN; Savitskaia, KI; Savov, AM | 1 |
| Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G | 1 |
| Cederberg, A; Forssell, H; Ohlin, B; Solhaug, JH; Tveit, E | 1 |
| Carbon, C; Carlet, J; Dupont, H | 1 |
| Li, JT; Zhang, YL | 1 |
| Cohen, J | 1 |
| Androulakakis, E; Dimitriou, L; Kafetzis, DA; Lebesii, E; Maltezou, HC; Nikolaidis, P | 1 |
2 review(s) available for tazobactam and Peritonitis
| Article | Year |
|---|---|
Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
Topics: Abdominal Abscess; Bacteremia; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam; Virulence | 1994 |
[Beta-lactamase inhibitor: tazobactam].
Topics: beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Penicillanic Acid; Peritonitis; Tazobactam | 1997 |
9 trial(s) available for tazobactam and Peritonitis
| Article | Year |
|---|---|
[Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections].
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2003 |
Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Topics: Abdomen; Abdominal Abscess; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1994 |
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Cholangitis; Cholecystitis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam | 1995 |
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cholangitis; Cholecystitis; Clindamycin; Combined Modality Therapy; Diverticulitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1993 |
[Use of piperacillin-tazobactam in abdominal surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Sepsis; Surgical Wound Infection; Tazobactam; Treatment Outcome | 1997 |
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam | 1998 |
Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Topics: Abdominal Abscess; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cefuroxime; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Intestinal Perforation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Rupture, Spontaneous; Surgical Wound Infection; Tazobactam | 1999 |
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Tazobactam; Treatment Outcome | 2000 |
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
Topics: Abdominal Abscess; Adolescent; Appendicitis; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2001 |
8 other study(ies) available for tazobactam and Peritonitis
| Article | Year |
|---|---|
Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model.
Topics: Animals; Anti-Bacterial Agents; Antigens, CD; beta-Lactamases; Cefotaxime; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Neoplasm Proteins; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2022 |
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Tazobactam | 2020 |
Topics: Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Clindamycin; Diagnosis, Differential; Female; Humans; Middle Aged; Penicillanic Acid; Penicillin G; Peritonitis; Piperacillin; Streptococcal Infections; Streptococcus pyogenes; Tazobactam; Treatment Outcome | 2018 |
[Initial empirical antimicrobial therapy with piperacillin/tazobactam in intra-abdominal infections due to perforation of the large intestine and rectum and in postoperative complications after resection of the large intestine and rectum].
Topics: Abdominal Abscess; Adult; Aged; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Intestinal Perforation; Intestine, Large; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Postoperative Complications; Rectal Diseases; Retrospective Studies; Surgical Wound Dehiscence; Tazobactam | 2002 |
Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Interleukin-1; Male; Ozone; Penicillanic Acid; Peritonitis; Piperacillin; Pneumoperitoneum; Rats; Rats, Wistar; Tazobactam; Tumor Necrosis Factor-alpha | 2006 |
Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; DNA-Binding Proteins; Drug Synergism; Enterococcus faecalis; Escherichia coli; Granulocyte Colony-Stimulating Factor; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Peptides, Cyclic; Peritonitis; Piperacillin; Survival Rate; Tazobactam; Time Factors | 2008 |
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Tazobactam; Treatment Outcome | 2008 |
Combination antibiotic therapy for severe peritonitis.
Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Penicillins; Peritonitis; Polypharmacy; Tazobactam | 2000 |